Cargando…

Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues

Ovarian seromucinous tumors were introduced in the 2014 World Health Organization (WHO) classification as one of the seven types of ovarian epithelial tumors. They are characterized by frequent association with endometriosis and bilaterality, microscopic appearance of papillary architecture, and adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagamine, Michiko, Mikami, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168900/
https://www.ncbi.nlm.nih.gov/pubmed/32023964
http://dx.doi.org/10.3390/diagnostics10020077
_version_ 1783523737985875968
author Nagamine, Michiko
Mikami, Yoshiki
author_facet Nagamine, Michiko
Mikami, Yoshiki
author_sort Nagamine, Michiko
collection PubMed
description Ovarian seromucinous tumors were introduced in the 2014 World Health Organization (WHO) classification as one of the seven types of ovarian epithelial tumors. They are characterized by frequent association with endometriosis and bilaterality, microscopic appearance of papillary architecture, and admixture of a variety of müllerian-type epithelium. They are considered to be endometriosis-related ovarian neoplasms, along with endometrioid and clear cell tumors; recent molecular studies suggest this particular tumor is a variant of endometrioid tumor. Discrepancies in nomenclature, definition, and morphology of seromucinous tumors appear to be a source of confusion, for both clinicians and general surgicalpathologists. This review summarizes the clinicopathological features of benign, borderline, and malignant seromucinous tumors, as well as controversies regarding these tumors.
format Online
Article
Text
id pubmed-7168900
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71689002020-04-20 Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues Nagamine, Michiko Mikami, Yoshiki Diagnostics (Basel) Review Ovarian seromucinous tumors were introduced in the 2014 World Health Organization (WHO) classification as one of the seven types of ovarian epithelial tumors. They are characterized by frequent association with endometriosis and bilaterality, microscopic appearance of papillary architecture, and admixture of a variety of müllerian-type epithelium. They are considered to be endometriosis-related ovarian neoplasms, along with endometrioid and clear cell tumors; recent molecular studies suggest this particular tumor is a variant of endometrioid tumor. Discrepancies in nomenclature, definition, and morphology of seromucinous tumors appear to be a source of confusion, for both clinicians and general surgicalpathologists. This review summarizes the clinicopathological features of benign, borderline, and malignant seromucinous tumors, as well as controversies regarding these tumors. MDPI 2020-01-31 /pmc/articles/PMC7168900/ /pubmed/32023964 http://dx.doi.org/10.3390/diagnostics10020077 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nagamine, Michiko
Mikami, Yoshiki
Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
title Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
title_full Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
title_fullStr Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
title_full_unstemmed Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
title_short Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
title_sort ovarian seromucinous tumors: pathogenesis, morphologic spectrum, and clinical issues
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168900/
https://www.ncbi.nlm.nih.gov/pubmed/32023964
http://dx.doi.org/10.3390/diagnostics10020077
work_keys_str_mv AT nagaminemichiko ovarianseromucinoustumorspathogenesismorphologicspectrumandclinicalissues
AT mikamiyoshiki ovarianseromucinoustumorspathogenesismorphologicspectrumandclinicalissues